| Literature DB >> 9067864 |
C Ye1, C L Ho-Pao, M Kanazirska, S Quinn, K Rogers, C E Seidman, J G Seidman, E M Brown, P M Vassilev.
Abstract
The amyloid-beta peptides (A beta) are produced in excess in Alzheimer's disease (AD) and may contribute to neuronal dysfunction and degeneration. This study provides strong evidence for a novel cellular target for the actions of A beta, the phospholipase C-coupled, extracellular Ca(2+)-sensing receptor (CaR). We demonstrate that A beta(s) produce a CaR-mediated activation of a Ca(2+)-permeable, nonselective cation channel (NCC), probably via elevation in cytosolic Ca2+ (Cai), in cultured hippocampal pyramidal neurons from normal rats and from wild type mice but not those from mice with targeted disruption of the CaR gene (CaR -/-). A beta(s) also activate NCC in CaR-transfected but not in nontransfected human embryonic kidney (HEK293) cells. Thus aggregates of A beta deposited on hippocampal neurons in AD could appropriately activate the CaR, stimulating Ca(2+)-permeable channels and causing sustained elevation of Cai with resultant neuronal dysfunction.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9067864 DOI: 10.1002/(sici)1097-4547(19970301)47:5<547::aid-jnr10>3.0.co;2-v
Source DB: PubMed Journal: J Neurosci Res ISSN: 0360-4012 Impact factor: 4.164